2m 2m 2m 2m 2m 2m 2m
Johnson&Johnson (JNJ)
NYSE
$270.62-$2.43 (-0.89%)
Price as of Aug 25, 2026 7:09 AM EDT- $658.0BMarket Cap
- 56.86%1-Year Change
- Drug Manufacturers - GeneralIndustry
Johnson&Johnson (JNJ)
$270.62-$2.43 (-0.89%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD GROUP INC | 9.97% | 240.3M | +3.7M (+1.55%) | Dec 31, 2025 |
BLACKROCK, INC. | 8.80% | 212.1M | -1.3M (-0.61%) | Jun 30, 2026 |
BLACKROCK FUNDING, INC. /DE | 8.35% | 201.3M | +1.4M (+0.68%) | Dec 31, 2024 |
BLACKROCK INC. | 8.22% | 198.2M | +8.5M (+4.27%) | Jun 30, 2024 |
VANGUARD CAPITAL MANAGEMENT LLC | 6.52% | 157.2M | +621,004 (+0.39%) | Jun 30, 2026 |
STATE STREET CORP | 5.55% | 133.8M | +299,737 (+0.22%) | Jun 30, 2026 |
BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A. | 3.11% | 74.8M | +30,133 (+0.04%) | Dec 31, 2016 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD INDEX FUNDS | 6.76% | 162.9M | +1.4M (+0.87%) | Mar 31, 2026 |
FIDELITY CONCORD STREET TRUST | 1.64% | 39.4M | +355,870 (+0.90%) | May 31, 2026 |
DFA INVESTMENT DIMENSIONS GROUP INC | 1.26% | 30.4M | 0 (0.00%) | Apr 30, 2026 |
SPDR S&P 500 ETF TRUST | 1.16% | 28.1M | -1.3M (-4.54%) | Mar 31, 2026 |
VANGUARD FIXED INCOME SECURITIES FUNDS | 0.93% | 22.3M | 0 (0.00%) | Apr 30, 2026 |
VANGUARD SPECIALIZED FUNDS | 0.90% | 21.8M | -259,456 (-1.19%) | Apr 30, 2026 |
SELECT SECTOR SPDR TRUST | 0.73% | 17.5M | +507,644 (+2.89%) | Mar 31, 2026 |
Current Ownership Distribution
- Institutions33.0B (81.01%)
- Mutual Funds7.6B (18.53%)
- Insiders187.6M (0.46%)
- Other0 (0.00%)
Insider Transactions
- 0.46% (187.6M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 10Number of InsiderSelling (last 12 months)
- $404.5MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Duato Joaquin CEO and Chairman of the Board | Exempt | Aug 13, 2026 | $0.00 | 123,291 | $0.00 | 0 |
Duato Joaquin CEO and Chairman of the Board | Exempt | Aug 13, 2026 | $14.3M | 123,291 | $115.67 | 399,258 |
Duato Joaquin CEO and Chairman of the Board | Sell | Aug 13, 2026 | $5.5M | 20,976 | $262.00 | 378,282 |
Duato Joaquin CEO and Chairman of the Board | Sell | Aug 13, 2026 | $26.7M | 102,315 | $261.00 | 275,967 |
Forminard Elizabeth EVP, Chief Legal Officer | Exempt | Aug 06, 2026 | $0.00 | 9,344 | $0.00 | 0 |
Forminard Elizabeth EVP, Chief Legal Officer | Exempt | Aug 06, 2026 | $1.2M | 9,344 | $131.94 | 32,912 |
Forminard Elizabeth EVP, Chief Legal Officer | Sell | Aug 06, 2026 | $2.4M | 9,344 | $257.75 | 23,568 |
Forminard Elizabeth EVP, Chief Legal Officer | Sell | Aug 06, 2026 | $1.7M | 6,574 | $255.93 | 16,994 |
Duato Joaquin CEO and Chairman of the Board | Sell | Aug 05, 2026 | $10.8M | 41,957 | $258.06 | 282,490 |
Duato Joaquin CEO and Chairman of the Board | Sell | Aug 05, 2026 | $1.7M | 6,523 | $258.74 | 275,967 |
Wengel Kathryn E EVP, Chief TO and Risk Officer | Exempt | Jun 11, 2026 | $0.00 | 10,000 | $0.00 | 32,965 |
Wengel Kathryn E EVP, Chief TO and Risk Officer | Exempt | Jun 11, 2026 | $1.2M | 10,000 | $115.67 | 124,288 |
Wengel Kathryn E EVP, Chief TO and Risk Officer | Sell | Jun 11, 2026 | $2.4M | 10,000 | $241.15 | 114,288 |
Pinto Daniel E | Award | Jun 09, 2026 | $31,249.96 | 134 | $232.79 | 2,321 |
Pinto Daniel E | Award | Mar 10, 2026 | $31,250.10 | 129 | $242.14 | 462 |
Woods Eugene A. | Award | Mar 10, 2026 | $37,499.98 | 155 | $242.14 | 5,240 |
Decker Robert J VP Corporate Controller | Exempt | Feb 27, 2026 | $0.00 | 4,075 | $0.00 | 0 |
Decker Robert J VP Corporate Controller | Exempt | Feb 27, 2026 | $471,355.25 | 4,075 | $115.67 | 27,757 |
Decker Robert J VP Corporate Controller | Sell | Feb 27, 2026 | $1.0M | 4,075 | $247.87 | 23,682 |
Schmid Timothy EVP, WW Chair, MedTech | Sell | Feb 20, 2026 | $324,762.52 | 1,322 | $245.66 | 25,447 |
Schmid Timothy EVP, WW Chair, MedTech | Exempt | Feb 18, 2026 | $0.00 | 13,625 | $0.00 | 0 |
Schmid Timothy EVP, WW Chair, MedTech | Exempt | Feb 18, 2026 | $0.00 | 8,998 | $0.00 | 0 |
Schmid Timothy EVP, WW Chair, MedTech | Exempt | Feb 18, 2026 | $1.6M | 13,625 | $115.67 | 40,394 |
Schmid Timothy EVP, WW Chair, MedTech | Sell | Feb 18, 2026 | $3.3M | 13,625 | $244.20 | 26,769 |
Schmid Timothy EVP, WW Chair, MedTech | Exempt | Feb 18, 2026 | $1.2M | 8,998 | $129.51 | 35,767 |
Schmid Timothy EVP, WW Chair, MedTech | Sell | Feb 18, 2026 | $2.2M | 8,998 | $244.53 | 26,769 |
REED JOHN C EVP, Innovative Medicine, R&D | Exempt | Feb 17, 2026 | $0.00 | 21,721 | $0.00 | 21,721 |
Swanson James D. EVP, CIO | Exempt | Feb 17, 2026 | $0.00 | 20,521 | $0.00 | 0 |
REED JOHN C EVP, Innovative Medicine, R&D | Exempt | Feb 17, 2026 | $0.00 | 29,927 | $0.00 | 59,854 |
Wolk Joseph J Exec VP, CFO | Exempt | Feb 17, 2026 | $2.2M | 19,241 | $115.67 | 58,202 |